New drug cocktail shows promise for Hard-to-Treat myeloma
NCT ID NCT02718833
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This study tests a combination of four drugs—elotuzumab, pomalidomide, bortezomib, and dexamethasone—in people with multiple myeloma that has returned or stopped responding to prior treatments. The goal is to see how many patients achieve at least a partial response and to monitor side effects. The study involves 52 adults who have already tried at least two other therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Mass General/North Shore Cancer Center
Danvers, Massachusetts, 01923, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
Newton-Wellesley Hospital
Newton, Massachusetts, 02462, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Rochester
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.